Longitudinal analysis of CA19‐9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis

Longitudinal analysis of CA19‐9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis
复制标题

DOI：
10.1111/apt.15146
复制
发表时间：
2019-01
期刊：
Alimentary Pharmacology & Therapeutics
影响因子：
7.6
通讯作者：
A. Wannhoff;M. Brune;J. Knierim;K. Weiss;C. Rupp;D. Gotthardt
A. Wannhoff;M. Brune;J. Knierim;K. Weiss;C. Rupp;D. Gotthardt
中科院分区：
医学1区
文献类型：
--
作者：
A. Wannhoff;M. Brune;J. Knierim;K. Weiss;C. Rupp;D. Gotthardt

文献摘要

相似文献

原发性硬化性胆管炎与胆道癌风险增加有关。碳水化合物抗原19‐9 （CA19‐9）可用于筛查这些恶性肿瘤。
Primary sclerosing cholangitis is associated with an increased risk of biliary tract cancer. Carbohydrate antigen 19‐9 (CA19‐9) can be used to screen for these malignancies.